Elisabetta Magrini

Akt Phosphorylation and Gefitinib Efficacy in Patients With Advanced Non-Small-Cell Lung Cancer

Federico Cappuzzo, Elisabetta Magrini, Giovanni Luca Ceresoli et al. · JNCI Journal of the National Cancer Institute · 2004 · 367 citations · Full text

Medicine, Oncology, Pharmacology +17

Gefitinib in Pretreated Non–Small-Cell Lung Cancer (NSCLC): Analysis of Efficacy and Correlation With HER2 and Epidermal Growth Factor Receptor Expression in Locally Advanced or Metastatic NSCLC

Federico Cappuzzo, Vanesa Gregorc, Elisa Rossi et al. · Journal of Clinical Oncology · 2003 · 214 citations

Medicine, Oncology, Pharmacology +17

Prospective Study of Gefitinib in Epidermal Growth Factor Receptor Fluorescence In Situ Hybridization–Positive/Phospho-Akt–Positive or Never Smoker Patients With Advanced Non–Small-Cell Lung Cancer: The ONCOBELL Trial

Federico Cappuzzo, Claudia Ligorio, Pasi A. Jänne et al. · Journal of Clinical Oncology · 2007 · 211 citations

Medicine, Oncology, Pharmacology +15

Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib

Federico Cappuzzo, Luca Toschi, Giovanni Tallini et al. · Annals of Oncology · 2006 · 97 citations · Full text

Medicine, Oncology, Pharmacotherapy +10

EGFR and HER2 Gene Copy Number and Response to First-Line Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer (NSCLC)

Federico Cappuzzo, C. Ligorio, Luca Toschi et al. · Journal of Thoracic Oncology · 2007 · 90 citations · Full text

Medicine, Molecular Genetics, Oncology +16